Who are the key players in the Adbry/Adtralza Market Report 2026 market?

Major companies operating in the Adbry/Adtralza Market Report 2026 market are Major companies operating in the adbry/adtralza market are LEO Pharma Inc. Read More

What are the major opportunities in the Adbry/Adtralza market? What are the strategies for the Adbry/Adtralza market?

For detailed insights on the major opportunities and strategies in the Adbry/Adtralza market, Read More

How does the Adbry/Adtralza market relate to the overall economy and other similar markets?

For detailed insights on Adbry/Adtralza's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Adbry/Adtralza industry?

For detailed insights on the mergers and acquisitions in the Adbry/Adtralza industry, Read More

What are the key dynamics influencing the Adbry/Adtralza market growth? SWOT analysis of the Adbry/Adtralza market.

For detailed insights on the key dynamics influencing the Adbry/Adtralza market growth and SWOT analysis of the Adbry/Adtralza industry, Read More

Adbry/Adtralza Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Adbry/Adtralza Market Report 2026

Name: Adbry/Adtralza Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Adbry/Adtralza Market Overview

• The Adbry/Adtralza market growth in the historic period has been driven by limitations of topical corticosteroids, rising prevalence of atopic dermatitis

• Market expansion is supported by growing eczema patient population, expansion into pediatric use

• Growth Driver: Rising Atopic Dermatitis Prevalence Fuels Growth of Adbry/Adtralza Market

• Market Trend: Advancements In Biologic Treatments For Atopic Dermatitis With Leo Pharma's Expansion Of Adbry (Tralokinumab-ldrm) Approval

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Adbry/Adtralza Market?

Adbry (also known as adtralza) is a monoclonal antibody medication used to treat moderate to severe eczema (atopic dermatitis) in adults and children aged 6 years and older. It works by inhibiting interleukin-13 (IL-13), a protein involved in the inflammatory process of eczema. By targeting IL-13, Adbry/Adtralza helps reduce skin inflammation, itching, and rashes.

The main indication for adbry/adtralza are atopic dermatitis, other dermatological conditions. Atopic dermatitis (AD) is a chronic skin condition characterized by itchy, inflamed skin that can lead to significant discomfort and impact daily life. These are distributed through various distribution channels such as hospital and clinics, retail and specialty pharmacies and are used by various end users such as adult patients, geriatric patients.

Adbry/Adtralza Market Global Report 2026 Market Report bar graph

What Is The Adbry/Adtralza Market Size and Share 2026?

The growth in the historic period can be attributed to limitations of topical corticosteroids, rising prevalence of atopic dermatitis, success of monoclonal antibody treatments, dermatologist acceptance of biologics, regulatory approvals for il targeted therapies.

What Is The Adbry/Adtralza Market Growth Forecast?

The growth in the forecast period can be attributed to growing eczema patient population, expansion into pediatric use, increasing biologic therapy awareness, improved reimbursement coverage, continued innovation in dermatology biologics. Major trends in the forecast period include rising adoption of targeted dermatology biologics, growing use in moderate to severe atopic dermatitis, expansion of il 13 targeted therapies, increasing long term maintenance biologic therapy, higher patient demand for steroid sparing treatments.

Book your 30 minutes free consultation with our research experts

Global Adbry/Adtralza Market Segmentation

1) By Indication: Atopic Dermatitis, Other Dermatological Conditions,

2) By Distribution Channel: Hospital and Clinics, Retail and Specialty Pharmacies

3) By End User: Adult Patients, Geriatric Patients

What Are The Drivers Of The Adbry/Adtralza Market?

The rising prevalence of atopic dermatitis is expected to propel the growth of the adbry/adtralza market going forward. Atopic dermatitis, commonly known as eczema, refers to a chronic inflammatory skin condition characterized by intense itching, redness, and irritation. The rising prevalence of atopic dermatitis is due to factors such as increased air pollution, urban living conditions, changes in childhood skin care practices, and genetic predispositions. Adbry/adtralza, a monoclonal antibody targeting the interleukin-13 (IL-13) pathway, helps atopic dermatitis by reducing inflammation and immune system overactivity, thereby alleviating symptoms such as itching, redness, and skin irritation in patients with moderate-to-severe forms of the condition. For instance, in December 2023, according to the National Library of Medicine (NLM), a US-based biomedical library, the global prevalence of atopic dermatitis is estimated at 2.6%, affecting approximately 204.05 million people worldwide, with about 101.27 million adults and 102.78 million children diagnosed with the condition. Therefore, the rising prevalence of atopic dermatitis is driving the adbry/adtralza industry.

The rising healthcare expenditure is expected to propel the growth of adbry/adtralza market going forward. Healthcare expenditure refers to the total amount spent on health services and related activities within a certain period, typically measured annually. Healthcare expenditure refers to the total amount of money spent on healthcare services and products within a specific period. Healthcare expenditure plays a crucial role in supporting the availability and accessibility of innovative treatments such as Adbry (also known as adtralza), as increased spending on healthcare systems enables the coverage and distribution of advanced biologics for the management of conditions such as moderate-to-severe atopic dermatitis, improving patient outcomes while also facilitating broader access to these essential therapies. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the rising healthcare expenditure is driving the growth of adbry/adtralza industry.

Key Players In The Global Adbry/Adtralza Market

Major companies operating in the adbry/adtralza market are LEO Pharma Inc.

Global Adbry/Adtralza Market Trends and Insights

Major companies operating in the adbry/adtralza market are focusing on developing approved drugs such as biologic treatment specifically designed to inhibit interleukin-13 (IL-13) to gain improved therapeutic outcomes for patients with atopic dermatitis. Biologic treatment refers to a type of therapy that uses biologically derived substances, such as monoclonal antibodies, proteins, or vaccines, to target specific components of the immune system or cellular processes involved in diseases, offering a more targeted and often more effective approach for conditions like autoimmune disorders, cancer, and chronic inflammatory diseases. For instance, in December 2023, Leo Pharma, a Denmark-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of Adbry (tralokinumab-ldrm) to include pediatric patients aged 12 to 17 years with moderate-to-severe atopic dermatitis (AD). This marks Adbry as the first and only biologic specifically designed to inhibit interleukin-13 (IL-13), a key cytokine involved in the inflammatory processes of atopic dermatitis.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the adbry/adtralza market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Adbry/Adtralza Market?

The adbry/adtralza market consists of sales of adbry (Tralokinumab-ldrm), adtralza (Tralokinumab), delgocitinib, TMB-001, and fucidin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adbry/Adtralza Market Report 2026?

The adbry/adtralza market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adbry/adtralza industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Adbry/Adtralza Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Indication, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	LEO Pharma Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Adbry/Adtralza Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Adbry/Adtralza Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Adbry/Adtralza Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Adbry/Adtralza Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Dermatology Biologics

4.2.2 Growing Use In Moderate To Severe Atopic Dermatitis

4.2.3 Expansion Of IL 13 Targeted Therapies

4.2.4 Increasing Long Term Maintenance Biologic Therapy

4.2.5 Higher Patient Demand For Steroid Sparing Treatments

5. Adbry/Adtralza Market Analysis Of End Use Industries

5.1 Dermatology Clinics

5.2 Hospitals

5.3 Specialty Care Centers

5.4 Academic Medical Centers

5.5 Pediatric Dermatology Clinics

6. Adbry/Adtralza Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Adbry/Adtralza Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Adbry/Adtralza PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Adbry/Adtralza Market Size, Comparisons And Growth Rate Analysis

7.3. Global Adbry/Adtralza Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Adbry/Adtralza Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Adbry/Adtralza Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Adbry/Adtralza Market Segmentation

9.1. Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Atopic Dermatitis, Other Dermatological Conditions

9.2. Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital and Clinics, Retail and Specialty Pharmacies

9.3. Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Geriatric Patients

10. Adbry/Adtralza Market Regional And Country Analysis

10.1. Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Adbry/Adtralza Market

11.1. Asia-Pacific Adbry/Adtralza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Adbry/Adtralza Market

12.1. China Adbry/Adtralza Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Adbry/Adtralza Market

13.1. India Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Adbry/Adtralza Market

14.1. Japan Adbry/Adtralza Market Overview

14.2. Japan Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Adbry/Adtralza Market

15.1. Australia Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Adbry/Adtralza Market

16.1. South Korea Adbry/Adtralza Market Overview

16.2. South Korea Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Adbry/Adtralza Market

17.1. Western Europe Adbry/Adtralza Market Overview

17.2. Western Europe Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Adbry/Adtralza Market

18.1. UK Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Adbry/Adtralza Market

19.1. Germany Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Adbry/Adtralza Market

20.1. France Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Adbry/Adtralza Market

21.1. Eastern Europe Adbry/Adtralza Market Overview

21.2. Eastern Europe Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Adbry/Adtralza Market

22.1. North America Adbry/Adtralza Market Overview

22.2. North America Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Adbry/Adtralza Market

23.1. USA Adbry/Adtralza Market Overview

23.2. USA Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Adbry/Adtralza Market

24.1. Canada Adbry/Adtralza Market Overview

24.2. Canada Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Adbry/Adtralza Market

25.1. South America Adbry/Adtralza Market Overview

25.2. South America Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Adbry/Adtralza Market

26.1. Middle East Adbry/Adtralza Market Overview

26.2. Middle East Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Adbry/Adtralza Market

27.1. Africa Adbry/Adtralza Market Overview

27.2. Africa Adbry/Adtralza Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Adbry/Adtralza Market Regulatory and Investment Landscape

29. Adbry/Adtralza Market Competitive Landscape And Company Profiles

29.1. Adbry/Adtralza Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Adbry/Adtralza Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Adbry/Adtralza Market Company Profiles

29.3.1. LEO Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Adbry/Adtralza Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Adbry/Adtralza Market

32. Adbry/Adtralza Market High Potential Countries, Segments and Strategies

32.1 Adbry/Adtralza Market In 2030 - Countries Offering Most New Opportunities

32.2 Adbry/Adtralza Market In 2030 - Segments Offering Most New Opportunities

32.3 Adbry/Adtralza Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Adbry/Adtralza Market, Overview Of Key Products - Product Examples

Table 2: Global Adbry/Adtralza Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Adbry/Adtralza Market, Supply Chain Analysis

Table 4: Global Adbry/Adtralza Market, Major Raw Material Providers

Table 5: Global Adbry/Adtralza Market, Major Resource Providers

Table 6: Global Adbry/Adtralza Market, Major Manufacturers (Suppliers)

Table 7: Global Adbry/Adtralza Market, Major Distributors And Channel Partners

Table 8: Global Adbry/Adtralza Market, Key Technologies & Future Trends

Table 9: Global Adbry/Adtralza Market, Major Trends

Table 10: Global Adbry/Adtralza Market, Major End Users

Table 11: Global Adbry/Adtralza Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Adbry/Adtralza Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Adbry/Adtralza Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Adbry/Adtralza Market - TAM, US$ Billion, 2025

Table 15: Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Adbry/Adtralza Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Adbry/Adtralza Market - Company Scoring Matrix

Table 73: LEO Pharma Inc. Financial Performance

Table 74: Global Adbry/Adtralza Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Adbry/Adtralza Market, Competitive Dashboard

Table 76: Global Adbry/Adtralza Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 78: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 79: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Adbry/Adtralza Market, Overview Of Key Products - Product Examples

Figure 2: Global Adbry/Adtralza Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Adbry/Adtralza Market, Supply Chain Analysis

Figure 4: Global Adbry/Adtralza Market, Major Raw Material Providers

Figure 5: Global Adbry/Adtralza Market, Major Resource Providers

Figure 6: Global Adbry/Adtralza Market, Major Manufacturers (Suppliers)

Figure 7: Global Adbry/Adtralza Market, Major Distributors And Channel Partners

Figure 8: Global Adbry/Adtralza Market, Key Technologies & Future Trends

Figure 9: Global Adbry/Adtralza Market, Major Trends

Figure 10: Global Adbry/Adtralza Market, Major End Users

Figure 11: Global Adbry/Adtralza Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Adbry/Adtralza Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Adbry/Adtralza Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Adbry/Adtralza Market - TAM, US$ Billion, 2025

Figure 15: Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Adbry/Adtralza Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Adbry/Adtralza Market - Company Scoring Matrix

Figure 73: LEO Pharma Inc. Financial Performance

Figure 74: Global Adbry/Adtralza Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Adbry/Adtralza Market, Competitive Dashboard

Figure 76: Global Adbry/Adtralza Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 78: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 79: Global, Adbry/Adtralza Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Smart Agriculture Market Report 2026 - Global Outlook – By Offering (Hardware, Software, Services), By Farm Size (Small, Medium, Large), By Application (Precision Farming, Livestock Monitoring, Precision Aquaculture, Pre...

Arthritis Monoclonal Antibodies Market Report 2026 - Global Outlook – By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriat...

Biosimilar Monoclonal Antibodies Market Report 2026 - Global Outlook – By Type (Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application (Chro...

Breast Cancer Monoclonal Antibodies Market Report 2026 - Global Outlook – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone The...

Conjugated Monoclonal Antibodies Market Report 2026 - Global Outlook – By Drugs (Adcetris, Kadcyla), By Technology (Cleavable Linker, Non-cleavable Linker), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lu...

Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologic...

Cancer Monoclonal Antibodies Market Report 2026 - Global Outlook – By Monoclonal Antibody Therapies (Avastin, Herceptin,Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Canc...

Frequently Asked Questions

How big is the Adbry/Adtralza Market?

The Adbry/Adtralza market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Adbry/Adtralza market growth?

The global Adbry/Adtralza market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Adbry/Adtralza market?

Some Key Players in the Adbry/Adtralza market Include, LEO Pharma Inc. .

What is the anticipated growth trend for the Adbry/Adtralza market?

Major trend in this market includes: Advancements In Biologic Treatments For Atopic Dermatitis With Leo Pharma's Expansion Of Adbry (Tralokinumab-ldrm) Approval. For further insights on this market. request a sample here

Which region has the most growth potential in the Adbry/Adtralza market?

North America was the largest region in the adbry/adtralza market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adbry/adtralza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.